Fintech PR
Announcing the shortlist for the 2024 Lionel Gelber Prize
Five titles being considered for best non-fiction book on international affairs published in English
TORONTO, WASHINGTON, LONDON and ROME, Feb. 8, 2024 /PRNewswire/ — The shortlist for the 2024 Lionel Gelber Prize shortlist has been selected by an international panel of practitioners, journalists and scholars. This will be the 34th awarding of the prize, which honours the world’s best book on international affairs published in English. The winner will receive $50,000 CAD and will be chosen from the following five titles:
- Power and Progress: Our 1000-year struggle over technology and prosperity, Daron Acemoglu and Simon Johnson (PublicAffairs, Hatchette Book Group)
- Underground Empire: How America weaponized the world economy, Henry Farrell and Abraham Newman (Macmillan, Henry Holt and Co. U.S.A.; Allen Lane, an imprint of Penguin Press, U.K.)
- Homelands: A personal history of Europe, Timothy Garton Ash (Yale University Press)
- Seven Crashes: The economic crises that shaped globalization, Harold James (Yale University Press)
- We, The Data: Human rights in the digital age, Wendy H. Wong (MIT Press)
“The jury has chosen five books that explore topics critical to our understanding of the forces that influence the global economy and international cooperation,” said Judith Gelber, Chair of the Lionel Gelber Prize Board. “They each exemplify the values of the Lionel Gelber Prize with elegant writing on important issues.”
This year’s shortlist was selected by the 2024 Lionel Gelber Prize Jury: Prof. Janice Gross Stein (Jury Chair), Prof. Rosa Brooks (Washington), Prof. Francis J. Gavin (Washington), Iain Martin (London) and Eric Reguly (Rome).
Winner Announcement:
The winner will be announced on March 6, 2024. The winning author will take part in a hybrid event hosted by the Munk School of Global Affairs & Public Policy on March 25, 2024.
About The Lionel Gelber Prize:
The Lionel Gelber Prize, a literary award for the world’s best non-fiction book on international affairs published in English, was founded in 1989 by Canadian diplomat Lionel Gelber. A cash prize of $50,000 CAD is awarded to the winner. The award is presented annually by University of Toronto’s Munk School of Global Affairs & Public Policy. For further information, please visit: https://gelber.munkschool.utoronto.ca/ or follow @gelberprize on Facebook and Twitter.
The 2024 Lionel Gelber Prize – Shortlisted Books and Authors
Power and Progress: Our 1000-year struggle over technology and prosperity, Daron Acemoglu and Simon Johnson (PublicAffairs, Hatchette Book Group)
About the authors:
Daron Acemoglu is Institute Professor of Economics at MIT, the university’s highest faculty honor. For the last twenty-five years, he has been researching the historical origins of prosperity, poverty, and the effects of new technologies on economic growth, employment, and inequality. Acemoglu is the recipient of several awards and honors, including the John Bates Clark Medal, awarded to economists under forty judged to have made the most significant contribution to economic thought and knowledge (2005); the BBVA Frontiers of Knowledge Award in economics, finance, and management for his lifetime contributions (2016), and the Kiel Institute’s Global Economy Prize in economics (2019). He is author (with James Robinson) of The Narrow Corridor and the New York Times bestseller Why Nations Fail.
Simon Johnson is the Ronald A. Kurtz Professor of Entrepreneurship in the Sloan School at MIT, where he is also head of the Global Economics and Management group. Previously chief economist at the International Monetary Fund, he has worked on global economic crises and recoveries for thirty years. Johnson has published more than 300 high-impact pieces in leading publications such as The New York Times, The Washington Post, The Wall Street Journal, The Atlantic, and Financial Times. He is author (with Jon Gruber) of Jump-Starting America, and (with James Kwak) of White House Burning and the national bestseller 13 Bankers. He works with entrepreneurs, elected officials, and civil society organizations around the world.
Underground Empire: How America weaponized the world economy, Henry Farrell and Abraham Newman (Macmillan, Henry Holt and Co. U.S.A.; Allen Lane, an imprint of Penguin Press, U.K.)
About the authors:
Henry Farrell is the SNF Agora Professor at Johns Hopkins SAIS, the 2019 winner of the Friedrich Schiedel Prize for Politics and Technology, Editor-in-Chief of The Monkey Cage at The Washington Post, and co-founder of the popular academic blog, Crooked Timber. A member of the Council on Foreign Relations, Farrell has written for publications such as The New York Times, the Financial Times, Foreign Affairs, Foreign Policy, The Washington Monthly, The Boston Review, Aeon, New Scientist, and The Nation.
Abraham L. Newman is a professor at the School of Foreign Service and Government Department at Georgetown University. Known for his research on the politics generated by globalization, he serves as a frequent commentator on international affairs, appearing on news programs ranging from Al Jazeera to Deutsche Welle and NPR. His work has been published in leading outlets like The New York Times, The Washington Post, Nature, Science, Foreign Affairs, Foreign Policy, Harvard Business Review, and Politico.
Homelands: A personal history of Europe, Timothy Garton Ash (Yale University Press)
About the author: Timothy Garton Ash is professor of European studies at the University of Oxford and senior fellow at the Hoover Institution, Stanford University. His books include The Magic Lantern, his eyewitness account of the revolutions of 1989; The File: A Personal History, based on reading his own Stasi file; and History of the Present. He lives in Oxford, England.
Seven Crashes: The economic crises that shaped globalization, Harold James (Yale University Press)
About the author: Harold James is the Claude and Lore Kelly Professor in European Studies and professor of history and international affairs at Princeton University. He is the author of numerous books, most recently The War of Words: A Glossary of Globalization (Yale, 2021) and Making a Modern Central Bank: The Bank of England 1979–2003 (Cambridge, 2020).
We, The Data: Human rights in the digital age, Wendy Wong (MIT Press)
About the author: Wendy H. Wong is a Professor of Political Science and Principal’s Research Chair at the University of British Columbia, Okanagan. She is the author of two award-winning books: Internal Affairs: How the Structure of NGOs Transforms Human Rights and (with Sarah S. Stroup) The Authority Trap: Strategic Choices of International NGOs.
Lani Krantz, Communications and Media Relations Specialist, Munk School of Global Affairs & Public Policy, University of Toronto, +1 (647) 407-4384 (text preferred), [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/announcing-the-shortlist-for-the-2024-lionel-gelber-prize-302057686.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
https://news.cision.com/eqt/i/eqt-ab-group,c3285895 |
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
China remains stabilizing force for global economic growth
-
Latest News5 days ago
Kylian Mbappé and Accor Forge Alliance to Empower Younger Generations
-
Latest News3 days ago
Martello Re announces closing of $1.3 billion capital raise consisting of $935 million in equity and a $360 million upsize of the Company’s credit facility
-
Latest News4 days ago
BioCatch completes best first half in company history, grows ARR by 43% YoY
-
Latest News4 days ago
Market Dojo Celebrates Prestigious Inclusion in Ardent Partners 2024 Strategic Sourcing Technology Advisor
-
Latest News2 days ago
Driving Innovation Forward: CFI Welcomes Seven-Time Formula 1™ World Champion Lewis Hamilton as new Global Brand Ambassador
-
Latest News2 days ago
KEYSTONE BANK HOLDS CUSTOMER FORUM, REITERATES COMMITMENT TO EXCELLENT SERVICE DELIVERY
-
Latest News5 days ago
COP28 President calls on all stakeholders to bring spirit of solidarity that delivered UAE Consensus to drive implementation and sustainable socio-economic development